DE69328128D1 - Granuläre zubereitung - Google Patents

Granuläre zubereitung

Info

Publication number
DE69328128D1
DE69328128D1 DE69328128T DE69328128T DE69328128D1 DE 69328128 D1 DE69328128 D1 DE 69328128D1 DE 69328128 T DE69328128 T DE 69328128T DE 69328128 T DE69328128 T DE 69328128T DE 69328128 D1 DE69328128 D1 DE 69328128D1
Authority
DE
Germany
Prior art keywords
administration
pharmaceutical preparation
preparation
granular pharmaceutical
tube
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69328128T
Other languages
English (en)
Other versions
DE69328128T2 (de
Inventor
Hiroaki Nakagami
Taketoshi Keshikawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Priority claimed from PCT/JP1993/001553 external-priority patent/WO1995011674A1/ja
Publication of DE69328128D1 publication Critical patent/DE69328128D1/de
Application granted granted Critical
Publication of DE69328128T2 publication Critical patent/DE69328128T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69328128T 1993-10-27 1993-10-27 Granuläre zubereitung Expired - Fee Related DE69328128T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP1993/001553 WO1995011674A1 (fr) 1992-04-28 1993-10-27 Preparation granulaire

Publications (2)

Publication Number Publication Date
DE69328128D1 true DE69328128D1 (de) 2000-04-20
DE69328128T2 DE69328128T2 (de) 2000-08-24

Family

ID=14070606

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69328128T Expired - Fee Related DE69328128T2 (de) 1993-10-27 1993-10-27 Granuläre zubereitung

Country Status (6)

Country Link
US (1) US6335036B1 (de)
AT (1) ATE190487T1 (de)
DE (1) DE69328128T2 (de)
DK (1) DK0729756T3 (de)
ES (1) ES2145065T3 (de)
RU (1) RU2143898C1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1174423A4 (de) 1999-03-31 2008-03-19 Arne Holmgren Substrate für die thioredoxin reduktase
WO2003077886A1 (fr) * 2002-03-20 2003-09-25 Hosokawa Micron Corporation Procede de fabrication de particules composites contenant un produit chimique
JP5503879B2 (ja) * 2008-02-28 2014-05-28 参天製薬株式会社 視神経障害を伴う眼疾患の予防又は治療剤
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
WO2023240092A1 (en) * 2022-06-06 2023-12-14 Sound Pharmaceuticals Inc. Ebselen containing oral dosage forms

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3027075A1 (de) 1980-07-17 1982-02-18 A. Nattermann & Cie GmbH, 5000 Köln Benzisoselenazolone, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3027073C2 (de) 1980-07-17 1985-03-07 A. Nattermann & Cie GmbH, 5000 Köln Pharmazeutische Präparate, enthaltend 2-Phenyl-1,2-benzisoselenazol-3(2H)-on
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
DE3226284A1 (de) 1982-07-14 1984-01-19 A. Nattermann & Cie GmbH, 5000 Köln Neue benzisoselenazolone, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
JPS5942313A (ja) * 1982-09-01 1984-03-08 Teijin Ltd ポリビニルポリピロリドンを用いた製剤
DE3407511A1 (de) 1984-03-01 1985-09-05 A. Nattermann & Cie GmbH, 5000 Köln Benzisoselenazolthione, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3616923A1 (de) 1986-05-20 1987-11-26 Nattermann A & Cie Neue pharmazeutische verwendung von 2-phenyl-1,2-benzisoselenazol-3(2h)-on
DE3620674A1 (de) * 1986-06-20 1987-12-23 Nattermann A & Cie Salbe zur behandlung von hauterkrankungen
JPH0755905B2 (ja) 1986-07-17 1995-06-14 第一製薬株式会社 肝臓疾患治療剤
US4778814A (en) * 1987-03-18 1988-10-18 Ciba-Geigy Corporation Method of treating ocular allergy by topical application of a 2-substituted-1,2-benzisoselenazol-3(2H)-one
DE3720493A1 (de) * 1987-06-20 1989-01-26 Nattermann A & Cie Arzneizubereitungen mit mikronisierten ebselen-kristallen
JPS6413522A (en) 1987-07-08 1989-01-18 Ricoh Kk Liquid crystal display device
DE3821392A1 (de) 1988-06-24 1989-12-28 Nattermann A & Cie Neue pharmazeutische verwendung von 2-phenyl-1,2-benzisoselenazol-3(2h)-on (ebselen)
DE3827093A1 (de) * 1988-08-10 1990-02-15 Nattermann A & Cie Verfahren zur herstellung von hochreinem ebselen
US5288734A (en) * 1988-10-29 1994-02-22 A. Nattermann & Cie Gmbh Stable parenteral solution of 2-phenyl-1.2-benzisoselenazol-3(2H)-one and process for producing the same
US5385726A (en) * 1990-08-06 1995-01-31 Rhone-Poulenc Rorer Gmbh Use of 2-phenyl-1,2-benzisoselenazol-3-(2H)-one
DE4024885C2 (de) 1990-08-06 2002-07-18 Nattermann A & Cie Verwendung von 2-Phenyl-1,2-benzisoselenazol-3(2H)-on
ES2177849T3 (es) * 1996-08-27 2002-12-16 Nattermann A & Cie Preparado farmaceutico, que contiene 2-fenil-1,2-benzoisoselenazol-3(2h)-ona, para el tratamiento de la enfermedad de alzheimer.

Also Published As

Publication number Publication date
DK0729756T3 (da) 2000-06-05
US6335036B1 (en) 2002-01-01
ATE190487T1 (de) 2000-04-15
RU2143898C1 (ru) 2000-01-10
DE69328128T2 (de) 2000-08-24
ES2145065T3 (es) 2000-07-01

Similar Documents

Publication Publication Date Title
DK0477333T3 (da) Farmaceutiske præparater
FI924247A0 (fi) En doseringsform foer frigoerande av medicin till tarmen.
WO2002000193A3 (en) Multiple stimulus reversible hydrogels
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
Quercia et al. Stability of omeprazole in an extemporaneously prepared oral liquid
NO924104L (no) Pulverformulering med flytekontrollert avgivelse
ATE73650T1 (de) Arzneimittel, die hohle, feine, roehrchenfoermige wirkstoffabgabesysteme enthalten.
ES445014A1 (es) Procedimiento de obtencion de preparaciones farmaceuticas noamargas, para la administracion oral.
ATE198152T1 (de) Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe
BE901328A (fr) Composition pharmaceutique a absorption reglee.
DE3860967D1 (de) Arzneimittel in form stabiler suspendiermittel freier sucralfat-suspensionen.
DE69328128D1 (de) Granuläre zubereitung
DE3367324D1 (en) Pharmaceutical products in sustained-release form, and their preparation process
DE69008107T2 (de) Zubereitung mit verzögerter Freigabe eines Hydrochlorids eines basischen Arzneistoffs.
KOMATSU et al. Biopharmaceutical evaluation of gelatin microcapsules of sulfonamides
EP0729756A4 (de) Granuläre zubereitung
KR870010082A (ko) 구아르(guar) 분말
RU96110213A (ru) Гранулированный фармацевтический препарат
ATE256134T1 (de) Sulfatierte phosphatidylinositole, ihre herstellung und verwendung
ATE169818T1 (de) Carbamazepin-arzneiform mit verzögerter wirkstofffreisetzung
GB1219026A (en) Tablet preparation
Rešić et al. Intravenous acetaminophen overdose: a case report of a therapeutic error
Nelson et al. Respite care for the severely disabled child.
TH26552A (th) วิธีการรักษา
Shidore et al. EFFECT OF AMMONIUM CHLORIDE AND SODIUM BICARBONATE ON PHARMACOIUNETICS OF THREE SULFONAMIDES

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee